Actinium Pharmaceuticals Company Profile (NYSE:ATNM)

About Actinium Pharmaceuticals

Actinium Pharmaceuticals logoActinium Pharmaceuticals, Inc. (Actinium) is a clinical-stage biopharmaceutical company engaged in developing cancer treatments. The Company is engaged in developing therapies for diseases using its alpha particle immunotherapy platform and other related technologies. The Company's products include Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), and Iomab-B, an antibody-drug construct containing iodine 131 (I-131). Actimab-A is in human clinical trials stage for acute myeloid leukemia (AML) and Iomab-B in clinical trial stage for use in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. Its products under development are monoclonal antibodies labeled with radioisotopes. It has four product candidates in clinical trials: Actimab-A (HuM195-Ac-225), Iomab-B (BC8-I-131), BC8-Y-90 and BC8-SA. It is pursuing development of Actimab-A and Iomab-B, while BC8-Y-90 and BC8-SA are in physician sponsored clinical phase I trials.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ATNM
  • CUSIP:
Key Metrics:
  • Previous Close: $1.70
  • 50 Day Moving Average: $1.70
  • 200 Day Moving Average: $1.85
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.87
  • P/E Growth: 0.00
  • Market Cap: $82.07M
  • Outstanding Shares: 47,717,000
Additional Links:

Analyst Ratings

Consensus Ratings for Actinium Pharmaceuticals (NYSE:ATNM) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Actinium Pharmaceuticals (NYSE:ATNM)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Actinium Pharmaceuticals (NYSE:ATNM)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Actinium Pharmaceuticals (NYSE:ATNM)
Current Year EPS Consensus Estimate: $-0.63 EPS
Next Year EPS Consensus Estimate: $-0.60 EPS

Dividends

Dividend History for Actinium Pharmaceuticals (NYSE:ATNM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Actinium Pharmaceuticals (NYSE:ATNM)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Actinium Pharmaceuticals (NYSE:ATNM)
DateHeadline
finance.yahoo.com logoThe Life Sciences Report Examines Actinium's Radioimmunotherapies (NYSE:ATNM)
finance.yahoo.com - August 18 at 12:01 PM
News IconRadioimmunotherapy 2.0: Actinium Sets Eyes on Bone Marrow Transplant and AML with Later Stage Programs (NYSE:ATNM)
www.investorideas.com - August 17 at 3:41 PM
nasdaq.com logoActinium Pharma Highlights Its Recent Progress And Corporate Milestones (NYSE:ATNM)
www.nasdaq.com - August 4 at 12:09 PM
finance.yahoo.com logoActinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Providing Update on Company Progress and Anticipated Milestones (NYSE:ATNM)
finance.yahoo.com - August 4 at 12:09 PM
biz.yahoo.com logoACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:ATNM)
biz.yahoo.com - August 4 at 12:09 PM
nasdaq.com logoActinum Pharma Conducts Investigator Meeting For Phase 3 Iomab-B Sierra Trial (NYSE:ATNM)
www.nasdaq.com - July 20 at 11:43 AM
finance.yahoo.com logoActinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial (NYSE:ATNM)
finance.yahoo.com - July 20 at 11:43 AM
News IconActinium Pharmaceuticals Incorporated (NYSEMKT:ATNM) Shorts Decreased by 4.94% After Short Covering - RiversideGazette.com (NYSE:ATNM)
www.riversidegazette.com - March 9 at 2:40 PM
News IconH.C. Wainwright Initiates Coverage on Actinium Pharmaceuticals Inc to Buy - Street Edition (NYSE:ATNM)
www.streetedition.net - March 7 at 2:19 PM
News IconActinium Pharmaceuticals Incorporated (NYSEMKT:ATNM) Sellers Covered 2.76% of Their Shorts - RiversideGazette.com (NYSE:ATNM)
www.riversidegazette.com - February 19 at 1:50 PM
wallstreet.org logoActinium Pharmaceuticals Inc Can't Be More Risky. The Stock Formed a Multiple Bottom Pattern - WallStreet.org (NYSE:ATNM)
www.wallstreet.org - February 3 at 1:15 PM
News IconRecent Broker Updates On Actinium Pharmaceuticals, Inc. (ATNM) - Risers & Fallers (NYSE:ATNM)
www.risersandfallers.com - January 27 at 1:07 PM
baystreet.ca logoActinium Pharmaceuticals: A Small Cap Stock To Watch In The Biotech Space (NYSE:ATNM)
ir.baystreet.ca - January 19 at 11:35 AM
istreetwire.com logoBiotech Stock to Watch: Actinium Pharmaceuticals Inc - iStreetWire (NYSE:ATNM)
www.istreetwire.com - January 16 at 12:30 PM
finance.yahoo.com logoActinium Pharmaceuticals to Present at Biotech Showcase 2016 (NYSE:ATNM)
finance.yahoo.com - January 11 at 8:00 AM
News IconActinium Pharmaceuticals Inc (ATNM) Short Interest Update (NYSE:ATNM)
www.wkrb13.com - January 9 at 5:48 AM
News IconShort Interest in Actinium Pharmaceuticals Inc (ATNM) Declines By 1.1% (NYSE:ATNM)
www.wkrb13.com - January 9 at 5:48 AM
News IconShort Interest in Actinium Pharmaceuticals Inc (ATNM) Declines By 1.1% (NYSE:ATNM)
www.wkrb13.com - January 9 at 4:52 AM
News IconShort Interest in Actinium Pharmaceuticals Inc (ATNM) Drops By 1.1% (NYSE:ATNM)
www.wkrb13.com - January 8 at 4:30 AM
finance.yahoo.com logoThis Company is Up +400% in a Month (NYSE:ATNM)
finance.yahoo.com - January 7 at 1:02 PM
News IconActinium Pharmaceuticals Inc (ATNM) Short Interest Update (NYSE:ATNM)
www.intercooleronline.com - January 6 at 10:01 PM
finance.yahoo.com logoActinium Pharmaceuticals (ATNM) in Focus: Stock Jumps 5.3% (NYSE:ATNM)
finance.yahoo.com - January 5 at 8:35 AM
News IconShort Interest in Actinium Pharmaceuticals Inc (ATNM) Drops By 1.1% (NYSE:ATNM)
www.watchlistnews.com - January 3 at 11:39 AM
News IconActinium Pharmaceuticals Inc (ATNM) Short Interest Down 1.1% in December (NYSE:ATNM)
www.watchlistnews.com - January 3 at 11:21 AM
News IconActinium Pharmaceuticals Inc (ATNM) Short Interest Down 1.1% in December (NYSE:ATNM)
www.wkrb13.com - January 3 at 11:01 AM
News IconActinium Pharmaceuticals Inc (ATNM) Sees Significant Drop in Short Interest (NYSE:ATNM)
www.watchlistnews.com - January 3 at 8:24 AM
finance.yahoo.com logoActinium Pharmaceuticals (ATNM) Jumps: Stock Up 7.2% (NYSE:ATNM)
finance.yahoo.com - December 29 at 8:15 AM
finance.yahoo.com logoActinium to Ring First Closing Bell of 2016 at the New York Stock Exchange (NYSE:ATNM)
finance.yahoo.com - December 28 at 7:00 AM
biz.yahoo.com logoACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Entry into a (NYSE:ATNM)
biz.yahoo.com - December 24 at 1:10 PM
finance.yahoo.com logoActinium and Memorial Sloan Kettering Cancer Center Sign Agreement in Respect of Certain Liquidity Matters (NYSE:ATNM)
finance.yahoo.com - December 24 at 1:00 PM
finance.yahoo.com logoFactors Moving Markets - Research Reports on UTStarcom Holdings, Rocket Fuel, American Midstream Partners and Actinium Pharmaceuticals (NYSE:ATNM)
finance.yahoo.com - December 22 at 8:10 AM
insidermonkey.com logoPharmaceutical And LNG Stocks Are Driving The Market Higher Today (NYSE:ATNM)
www.insidermonkey.com - December 21 at 3:52 PM
insidermonkey.com logoWhy Are These Stocks Surging Amid Today’s Gloomy Market? (NYSE:ATNM)
www.insidermonkey.com - December 17 at 12:46 PM
finance.yahoo.com logoActinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3 Trial to Proceed (NYSE:ATNM)
finance.yahoo.com - December 17 at 7:00 AM
biz.yahoo.com logoACTINIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a (NYSE:ATNM)
biz.yahoo.com - December 16 at 4:11 PM
finance.yahoo.com logoACTINIUM PHARMACEUTICALS, INC. Financials (NYSE:ATNM)
finance.yahoo.com - December 8 at 1:16 PM
finance.yahoo.com logoClinical Trial Results for Actimab-A Presented at the 57th American Society of Hematology Annual Meeting (NYSE:ATNM)
finance.yahoo.com - December 8 at 8:00 AM

Social

Actinium Pharmaceuticals (NYSE:ATNM) Chart for Monday, August, 29, 2016


Last Updated on 8/29/2016 by MarketBeat.com Staff